NCT07250256

Brief Summary

Radiographic and Histomorphometric Evaluation of Xenograft as a Socket Preservation Material in Maxillary Posterior Teeth: A Randomized-Controlled Clinical Study

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 16, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

November 26, 2025

Completed
Last Updated

November 26, 2025

Status Verified

November 1, 2025

Enrollment Period

2 years

First QC Date

August 16, 2025

Last Update Submit

November 23, 2025

Conditions

Keywords

SocketHealingbone formationhistomorphometery

Outcome Measures

Primary Outcomes (2)

  • Histomorphometric analysis

    Samples were first stained with hematoxylin and eosin (H\&E) to demonstrate the general tissue architecture, cellular distribution, and overall structural organization. Subsequently, sections were stained with Masson's Trichrome (MTC) to allow both qualitative and quantitative assessment of bone trabeculae and osteoid tissue. Osteopontin (OPN) immunohistochemistry was used to assess the percentage of OPN expression area within the surrounding connective tissue. The OPN poly-colonal antibody was purchased from Thermo Fisher Scientific, Catalog # PA1-72061. Images were captured at ×400 magnification using a SOPTOP EX20 microscope with HD camera. ImageJ software was used to quantify area% from five standardized fields per section at oral pathology laboratory, Faculty of Dentistry, Suez Canal University.

    16 weeks

  • Radiographic evaluation

    Cone-beam computed tomography (CBCT) scans (Scanora 3D) were obtained immediately after extraction at baseline and postponed at 4 months postoperatively to evaluate the following parameters: bone density that was measured in Hounsfield units (HU) at the center of the socket, ridge height that was determined by vertical distance from the crestal bone to a fixed reference point and ridge width that was measured at 3 mm apical to the crest.

    16 weeks

Study Arms (2)

Study group

ACTIVE COMPARATOR

(8 cases): was treated by immediate socket preservation with S1-XB xenograft augmentation after extraction.

Device: S1-XB

Control group

PLACEBO COMPARATOR

(8 cases): was not exposed to any type of socket preservation after the extraction procedure.

Procedure: Control (Standard treatment)

Interventions

S1-XBDEVICE

Socket grafted with xenograft containing alginate hydrogel material

Study group

Atraumatic extraction and sockets were allowed to undergo normal healing without any graft materials

Control group

Eligibility Criteria

Age21 Years - 40 Years
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsmales with general good health. Non smokers
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male patients aged between 21 and 40 years.
  • General good health.
  • Absence of any relevant systemic disease.
  • Presence of a hopeless maxillary posterior tooth that requires extraction.
  • Extraction site suitable for replacement by a dental implant.
  • Cases have adequate bone width and length.
  • Volunteer subjects must sign an informed consent.

You may not qualify if:

  • Poor oral hygiene with no possibility of improvement.
  • Smokers (more than 10 cigarettes per day).
  • Chronic treatment with any medication known to affect oral status and bone turnover.
  • Drug or alcohol abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Suez Canal university

Ismailia, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This is an In-Vivo comparative randomized controlled study that will be conducted on patients of the outpatient clinic of Oral and Maxillofacial department Suez Canal University to evaluate the difference between using S1-XB bone graft as a socket preservation material and normal socket healing without adding any socket preservation materials.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2025

First Posted

November 26, 2025

Study Start

August 1, 2022

Primary Completion

August 1, 2024

Study Completion

December 1, 2024

Last Updated

November 26, 2025

Record last verified: 2025-11

Locations